The University of Manchester

The University of Manchester

The University of Manchester

Overview
Date Founded

2004

Headquarters

Oxford Road,Manchester, Lancashire M13 9PL

Company Description

The University of Manchester (UoM) is a large research university situated in the city of Manchester, England. Manchester University - as it is commonly known - is a public university formed in 2004 by the merger of the University of Manchester Institute of Science and Technology (est. 1824) and the Victoria University of Manchester (est. 1851). Manchester is a member of the worldwide Universities Research Association group, the Russell Group of British research universities and the N8 Group. The University of Manchester is regarded as a "red brick university", and was a product of the civic university movement of the late 19th century. It formed a constituent part of the federal Victoria University between 1880, when it received its royal charter, and 1903-1904, when it was dissolved. The main campus is south of Manchester city centre on Oxford Road. In 2012, the university had around 39,000 students and 10,400 staff, making it the largest single-site university in the United Kingdom.[5] The University of Manchester had an income of £827 million in 2012–13, of which £200 million was from research grants and contracts.[6] In the 2008 Research Assessment Exercise,[7] Manchester came third in terms of research power and eighth for grade point average quality when including specialist institutions.[8] More students try to gain entry to the University of Manchester than to any other university in the country, with more than 60,000 applications for undergraduate courses.[9] According to the 2012 Highfliers Report, Manchester is the most targeted university by the Top 100 Graduate Employers.[10][11] In the 2012 Academic Ranking of World Universities, Manchester is ranked 40th in the world and 5th in the UK.[12] It is ranked 58th in the world and 12th in Europe in the 2014 Times Higher Education World University Rankings.[13] The university owns and operates major cultural assets such as the Manchester Museum, Whitworth Art Gallery, John Rylands Library and Jodrell Bank Observatory. The University of Manchester has 25 Nobel Laureates among its past and present students and staff, the third-highest number of any single university in the United Kingdom after Cambridge and Oxford. Four Nobel laureates are currently among its staff – more than any other British university.

Contact Data
Trying to get in touch with decision makers at The University of Manchester? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Vice Chancellor

Head, Politics

Head of Business Engagement

Assistant Director of Finance & Head of Faculty Finance

Director, Center for Applied Pharmacokinetic Research

Director, National Graphene Institute

Director of Finance

Director, Manchester Museum

Director of Finance

Director-Eurolens Research

Board of Directors

Chief Executive Officer at The Co-operative Financial Services

Distinguished Alumni
Alistair McGiven is now Managing Director & Head of Portfolio Management at Canada Pension Plan Investment Board
Brian Magnus is now Partner at TDR Capital LLP
Robert Herz is now Chief Executive Officer at Robert H. Herz LLC
Paths to The University of Manchester
Potential Connections via
Relationship Science
You
The University of Manchester
Recent Transactions
Details Hidden

Versarien Plc purchases 2-DTech Ltd. from The University of Manchester

Transaction Advisors
Legal Advisor

Advised onAtlas Venture, Inc. purchases Renovo Ltd. from The University of Manchester

Investment Advisor

Advised onCapcis Ltd. /Management purchases Capcis Ltd. from The University of Manchester

Advisors & Consultants
Advisor

Former Director at Manchester Cancer Research Centre

Clients

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX:BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.

Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA.

Non-Profit Donations & Grants Received
Investments
Details Hidden

MishiPay Ltd. develops payment processing solutions. Its platform allows shoppers to pick up a product they wish to buy, scan the barcode with their phone, and pay within the phone. The company was founded by Mustafa Khanwala and Tanvi Bhardwaj in August 2015 and is headquartered in London, the United Kingdom.

Details Hidden

Spectromics Ltd. develops novel and proprietary technologies. It provides a point-of-prescription test for bacterial infections that guides the treatment of antibiotics. The company was founded in 2014 and is headquartered in Manchester, the United Kingdom.

Details Hidden

Manchester Imaging Ltd. develops dental diagnostic software solutions. It operates as a platform technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare. The company was founded by Jim Graham and Hugh Devlin and is headquartered in Manchester, the United Kingdom.

Suppliers
Carillion Plc Engineering, Construction & Architecture | Wolverhampton, United Kingdom

Carillion Plc provides services for buildings, infrastructure, construction and engineering sectors. The company operates through the following business segments: Support Services, Middle East Construction Services, Construction services (excluding the Middle East) and Public Private Partnership Projects. The Support Services segment is engaged in the facilities management, facilities services, rail services, road maintenance, utility services and consultancy businesses. The Middle East Construction Services segment engages in the business of building and civil engineering activities in the Middle East and North Africa. The Public Private Partnership Projects reports equity returns from its investments in public private partnership projects. The Construction Services segment engages in the UK building, civil engineering and developments businesses, as well as construction activities in Canada. The company offers services for commercial property, defence, education, health, rail, regeneration, highway maintenance, FM, civil engineering, international, nuclear, secure, fleet management and utility services. Carillion was founded on July 29, 1999 and is headquartered in Wolverhampton, the United Kingdom.

Balfour Beatty Plc Engineering, Construction & Architecture | London, United Kingdom

Balfour Beatty Plc engages in the provision of infrastructure services. It offers a range of capabilities in construction, civil engineering and mechanical & electrical engineering services. It operates through following business segments: Construction Services, Support Services, Infrastructure Investments, and Corporate Activities. The Construction Services segment includes activities resulting in the physical construction of an asset. The Support Services segment supports existing assets or functions such as asset maintenance and refurbishment. The Infrastructure Investments segment involves in the acquisition, operation, and disposal of infrastructure assets such as roads, hospitals, student accommodation, military housing, offshore transmission networks, waste and biomass, and other concessions. The company was founded by George Balfour and Andrew Beatty on January 12, 1909 and is headquartered in London, the United Kingdom.

Severfield Plc Metal Manufacturing & Products | Thirsk, United Kingdom

Severfield Plc engages in the design, fabrication and construction of steel structures. It provides essential services, including power andenergy, health and education, leisure, commercial offices, transport, bridges, and distribution warehouse. The company was founded on December 29, 1978 and is headquartered in Thirsk, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by The University of Manchester. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of The University of Manchester's profile does not indicate a business or promotional relationship of any kind between RelSci and The University of Manchester.